Esophageal Neuroendocrine Carcinoma — Trials

Esophageal Neuroendocrine Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

5 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 3
Recruiting: 1
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (0)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03811379	Toripalimab as Monotherapy for Patients With Small Cell Carcinoma of Esophagus Who Failed Chemotherapy	unknown	Phase 2	43	Sun Yat-sen UniversityOTHER	1	Jan 23, 2019	clinicaltrials
NCT02409849	Octreotide LAR as Maintenance Treatment for Patients With NEC	unknown	Phase 2	92	Peking UniversityOTHER	1	Apr 7, 2015	clinicaltrials